Advertisement
Screener

EPIRUS Biopharmaceuticals, Inc. Total Liabilities

EPIRUS Biopharmaceuticals, Inc. Total Liabilities

EPIRUS Biopharmaceuticals, Inc. had Total Liabilities of $35.17 million as of 2016-03-31, per its 10-Q filed 2016-05-10.

Discontinued › Balance Sheet › Liabilities

us-gaap:Liabilities · last filed 2016-05-10

  • 2016-03-31: Liabilities $35.17M.
  • 2015-12-31: Liabilities $35.90M.
  • 2014-12-31: Liabilities $18.98M.
Period endLiabilities
2016-03-31$35.17M
10-Q · filed 2016-05-10
2015-12-31$35.90M
10-Q · filed 2016-05-10
2014-12-31$18.98M
10-K · filed 2016-03-29